RISE TECHNOLOGY SRL

Their core work

RISE TECHNOLOGY SRL is a Rome-based technology SME whose core competency appears to be in electrical and electronic systems, applied across radically different domains. In industrial settings, they contributed to automated manufacturing of photovoltaic cells and modules. In biomedical research, they work on electrically-driven implants for spinal cord regeneration — using microsecond electric pulses to manipulate cells, trigger calcium signalling, and support stem cell transplantation via a wireless-controlled electrified biohybrid scaffold. The common thread across both projects is precision electrical engineering: designing systems that apply controlled electrical energy to achieve specific physical or biological outcomes. Their small size and specialist profile suggest they bring niche hardware or electrical system expertise into larger research consortia.

What they specialise in

How they've shifted over time

RISE TECHNOLOGY entered H2020 in 2017 through the energy and manufacturing domain, contributing to photovoltaic cell production automation — a clean energy industrial application. By 2021, their focus had shifted entirely toward biomedical engineering, specifically neural regeneration using electrical pulse technology. This is a significant pivot, moving from clean energy manufacturing to deep biomedical research, though both domains share the same underlying electrical systems expertise that appears to be the company's true core. The trend suggests either a deliberate strategic reorientation toward biomedical devices, or that they are a generalist electrical technology firm opportunistically contributing to whichever funded projects match their capabilities.

RISE TECHNOLOGY is moving toward biomedical electrical engineering — specifically implantable devices and cell-level electrostimulation — which may signal a long-term repositioning away from energy into medtech or neurotechnology.

How they like to work

RISE TECHNOLOGY has participated in every H2020 project as a consortium partner, never as coordinator, indicating they operate as a specialist contributor rather than a project driver. Their two projects engaged 19 unique partners across 8 countries, suggesting they integrate well into mid-to-large international consortia. The absence of repeated partners across projects, and the jump between completely different domains, implies they are brought in for specific technical skills rather than as part of a stable long-term network.

RISE TECHNOLOGY has built connections with 19 unique partners across 8 countries through just two projects, suggesting each consortium was substantial in size. Their network spans both energy-sector industrial partners (from AMPERE) and biomedical research institutions (from RISEUP), giving them cross-domain reach despite their small footprint.

What sets them apart

RISE TECHNOLOGY occupies an unusual intersection: an Italian technology SME that has demonstrated competence in both clean energy manufacturing and bioelectrical medical devices, unified by expertise in controlled electrical systems. This cross-domain electrical engineering profile is rare and potentially valuable for consortia that need a hardware or systems partner who understands both industrial and biomedical constraints. However, their profile is thin — with only two projects and no coordinator experience, prospective partners should expect a focused technical contributor rather than a consortium anchor.

Highlights from their portfolio

• RISEUP
  The largest and most recent project (€505,625, 2021-2025) tackles spinal cord regeneration using an electropulsed biohybrid implant — a highly ambitious FET-class research topic placing RISE TECHNOLOGY at the frontier of neurotechnology and bioelectronics.
• AMPERE
  Demonstrates industrial manufacturing competence in the PV sector, showing that RISE TECHNOLOGY's electrical expertise is not limited to research but extends to production-scale automation in renewable energy.